Revolutionizing Pancreatic Cancer
With Targeted Immunotherapy
A pancreatic cancer diagnosis can be especially difficult to digest. Its cryptic symptoms and cell biology present unique challenges at every step, and chemotherapy tends to have little to no effect. In turn, patients undergoing treatment are often left with little to no energy… or hope.
The Immunocine Cancer Center safeguards these precious resources by skillfully harnessing the immune system’s natural intelligence.
The Immunocine Cancer Center:
The Body Knows Better
Pancreatic cancer is practically unrecognizable to chemotherapy drugs, as are its symptoms to patients and doctors. Clinical advances have amended weeks into years for some, but remission and survival rates remain gloomily low when compared stage-by-stage with other cancers.
Its cell shape poses a unique combination of limits that can make any monetary and bodily wealth spent on mainstream treatment options counterproductive. Since outward-facing approaches are often futile, Immunocine chooses to give the body a fighting chance from within.
Immunotherapy is a novel cancer treatment, so the majority of its triumphs against malignant pancreatic cells have occurred within the walls of a clinical setting where names are kept secret. One such story took place at the Providence Cancer Institute with sustained results.
A pancreatic cancer patient whose disease had severely progressed after undergoing chemotherapy, spreading to her lungs, chose to participate in a clinical trial involving immunotherapy in Portland, OR. After her T-cells were engineered to recognize and attack a KRAS protein mutation shared by a majority of patients, her tumor responded exceptionally well and her results were published in the New England Journal of Medicine.
Since related clinical trials are not always easy to come by, we aim to extend our hand to every patient who could use the same level of hope.
We treat cancer we believe we can help beat.
Our sole purpose is to facilitate cancer treatment for patients that can benefit, so we will not move forward if they do not meet our criteria.
We can only offer our services to those with a solid tumor at this time.
Immunotherapy can only attack cancer via a functioning immune system.
Our patients must come to Cancún to undergo immunotherapy.
Our treatment protocol calls for three sessions, separated by two weeks.
Unlocking the Unique Shape
of Pancreatic Cancer
Among the many atypical features of pancreatic cancer cells are tentacle-like structures that can extend into nerves and blood vessels and severely inhibit the safety and viability of tumor removal. Connective tissue surrounding the pancreas may also bar traditional procedures.
The immune system works freely from within these structures.
Early symptoms of pancreatic cancer are either non-specific or nonexistent and our current screening mechanisms wield no proven efficacy. It can easily metastasize before forming a single tumor and therefore is often found throughout the body at the time of diagnosis.
The immune system learns from every encounter with the same cell type.
A Much-Needed Makeover
for Medical Tourism
Proven Track Record
Our treatment is supported by 15+ years of research and 17+ publications, along with numerous clinical successes and patents.
Extensive Medical Background
In addition to expert medical specialists, our passionate staff includes integrative advisors and nutritionists.
Clean and Friendly Facility
We are here for healing, offering an exceptionally clean and comfortable space with smiling and empathetic staff.
Frequently Asked Questions
Immunotherapy triggers the body’s immune system to fight cancer cells.
Cancer can parade itself as harmless and spread without immune interference. Pancreatic cancer cells are particularly stealthy, and their unique shape often hides them from chemotherapy drugs too.
Dendritic cell immunotherapy changes this dynamic by loading a blueprint of these elusive cells directly into the dendritic cells of the patient.
Candidates for treatment at our facility must meet the following criteria:
-A stable immune system, so it can attack the cancer cells
-A solid tumor in a place our staff can reach to biopsy
-Ability to come to our facility in Cancún in increments
If someone is eligible for our pancreatic cancer protocol, our medical professionals will perform a comprehensive review of their medical records, free of charge. Once candidacy is confirmed after one to two weeks, our concierge team will reach out to start the planning process.
Throughout the treatment period, a patient may experience side effects similar to the flu, such as swollen lymph nodes, aches, fever, fatigue, and a decreased appetite. Some may also experience sleeping difficulties.
Side effects of dendritic cell therapy for pancreatic cancer are usually mild compared to those of other cancer treatments, including other types of immunotherapy. We also have integration advisors and nutritionists on staff to help dampen any discomfort that does occur.
Pancreatic cancer has a particularly low survival rate, and this sadly does not exclude those treated with immunotherapy. However, dendritic cell immunotherapy treatments have shown high promise in clinical trials.
Each time we administer our Immunocine Dendritic Cell Treatment to a pancreatic cancer patient, we have high hopes that it will not only lift them out of a dark place but shed light on the nature of their disease.
Apply today for a new approach to
your Pancreatic Cancer.
Once you submit your information form, we initiate a dedicated and personalized journey to provide you the most innovative prostate cancer treatments.
Step 1: Connecting with a Patient Coordinator
Upon receiving your submission, an Immunocine Patient Coordinator will contact you to schedule an introductory call.
This gives us an opportunity to get to know you, understand your needs better, and answer any preliminary questions you may have about our approach to prostate cancer.
Step 2: Complimentary Medical Evaluation
Following the introductory call, we’ll commence your complimentary medical evaluation.
Our goal during the medical evaluation is to determine if you will be a candidate for our treatment. We know waiting can be hard and we aim to complete this process in 3 – 5 business days.